\u5927\u6b63<\/a>, \u3001\u305d\u3057\u3066\u30bb\u30eb\u30c8\u30ea\u30aa\u30f3\u304c\u9023\u643a\u3057\u3066\u53d6\u308a\u7d44\u3093\u3067\u3044\u307e\u3059\u3002KG006\u81ea\u4f53\u306f\u3001\u81ea\u5df1\u514d\u75ab\u75be\u60a3\u306e\u6cbb\u7642\u3092\u76ee\u7684\u3068\u3057\u305fFcRn\u963b\u5bb3\u5264\u3067\u3042\u308a\u3001\u4f01\u696d\u5404\u793e\u304c\u3088\u308a\u512a\u308c\u305f\u6709\u52b9\u6027\u3068\u5b89\u5168\u6027\u3092\u5099\u3048\u305f\u6a19\u7684\u7642\u6cd5\u3092\u8ffd\u6c42\u3059\u308b\u4e2d\u3001\u3053\u306e\u5206\u91ce\u3078\u306e\u6295\u8cc7\u304c\u6700\u8fd1\u5897\u52a0\u3057\u3066\u3044\u307e\u3059\u3002 \u5168\u4f53\u3068\u3057\u3066\u3001\u3053\u306e\u63d0\u643a\u306f\u57fa\u672c\u7684\u306b\u3001\u30ab\u30a4\u30b8\u30a7\u30f3\u306e\u533b\u85ac\u54c1\u958b\u767a\u30ce\u30a6\u30cf\u30a6\u3068\u3001\u5927\u6b63\u88fd\u85ac\u306e\u65e5\u672c\u306e\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u5e02\u5834\u306b\u304a\u3051\u308b\u30ce\u30a6\u30cf\u30a6\u3092\u7d44\u307f\u5408\u308f\u305b\u305f\u3082\u306e\u3067\u3042\u308a\u3001\u3053\u306e\u6cbb\u7642\u6cd5\u3092\u5b9f\u969b\u306e\u5546\u696d\u5316\u306b\u4e00\u6b69\u8fd1\u3065\u3051\u308b\u3053\u3068\u3092\u76ee\u6a19\u3068\u3057\u3066\u3044\u307e\u3059\u3002.<\/p>","protected":false},"excerpt":{"rendered":"Kaigene has signed this exclusive licensing arrangement with Taisho Pharmaceutical, kind of to help build and then commercialize its next-generation autoimmune treatment KG006, specifically in Japan. So basically under the deal, Taisho will end up taking the lead for clinical development, regulatory approval, and the commercialization part in that country. Meanwihle Kaigene receives a $5 million upfront payment, and then milestone payments that follow the development, regulatory, and sales targets, plus tiered royalties later on from future net sales. Also Read: Kyoto University and BostonGene Boost Biomarker Discovery There\u2019s also a sort of bigger global development angle here because the pact sets up a framework for what looks like a […]<\/p>\n","protected":false},"author":7,"featured_media":37206,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,181,89,211,237,206],"tags":[14335,150,14334,14336,14337],"ppma_author":[572],"class_list":["post-37202","post","type-post","status-publish","format-standard","has-post-thumbnail","category-apac","category-biotech","category-health-tech","category-japan","category-news","category-regional","tag-asset-kg006","tag-biotech","tag-fcrn-inhibitor","tag-kaigene","tag-taisho-pharmaceutical"],"yoast_head":"\n
Kaigene Advances Autoimmune Drug Development<\/title>\n<meta name=\"description\" content=\"Kaigene's licensing agreement with Taisho Pharmaceutical marks a key step in advancing KG006 for autoimmune disease treatment in Japan.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/kaigene-expands-drug-pipeline-through-taisho-deal\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kaigene Advances Autoimmune Drug Development\" \/>\n<meta property=\"og:description\" content=\"Kaigene's licensing agreement with Taisho Pharmaceutical marks a key step in advancing KG006 for autoimmune disease treatment in Japan.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/kaigene-expands-drug-pipeline-through-taisho-deal\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-03T12:33:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/08\/Kaigene-Enters-into-Exclusive-Licensing-Agreement-with.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kaigene Advances Autoimmune Drug Development","description":"Kaigene's licensing agreement with Taisho Pharmaceutical marks a key step in advancing KG006 for autoimmune disease treatment in Japan.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/kaigene-expands-drug-pipeline-through-taisho-deal\/","og_locale":"ja_JP","og_type":"article","og_title":"Kaigene Advances Autoimmune Drug Development","og_description":"Kaigene's licensing agreement with Taisho Pharmaceutical marks a key step in advancing KG006 for autoimmune disease treatment in Japan.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/kaigene-expands-drug-pipeline-through-taisho-deal\/","og_site_name":"itbusinesstoday","article_published_time":"2026-08-03T12:33:01+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/08\/Kaigene-Enters-into-Exclusive-Licensing-Agreement-with.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/kaigene-expands-drug-pipeline-through-taisho-deal\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/kaigene-expands-drug-pipeline-through-taisho-deal\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"Kaigene Expands Drug Pipeline Through Taisho Deal","datePublished":"2026-08-03T12:33:01+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/kaigene-expands-drug-pipeline-through-taisho-deal\/"},"wordCount":198,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/kaigene-expands-drug-pipeline-through-taisho-deal\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/08\/Kaigene-Enters-into-Exclusive-Licensing-Agreement-with.webp","keywords":["Asset KG006","Biotech","FcRn inhibitor","Kaigene","Taisho Pharmaceutical"],"articleSection":["APAC","Biotech","Health Tech","Japan","News","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/kaigene-expands-drug-pipeline-through-taisho-deal\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/kaigene-expands-drug-pipeline-through-taisho-deal\/","name":"Kaigene Advances Autoimmune Drug Development","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/kaigene-expands-drug-pipeline-through-taisho-deal\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/kaigene-expands-drug-pipeline-through-taisho-deal\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/08\/Kaigene-Enters-into-Exclusive-Licensing-Agreement-with.webp","datePublished":"2026-08-03T12:33:01+00:00","description":"Kaigene's licensing agreement with Taisho Pharmaceutical marks a key step in advancing KG006 for autoimmune disease treatment in Japan.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/kaigene-expands-drug-pipeline-through-taisho-deal\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/biotech\/kaigene-expands-drug-pipeline-through-taisho-deal\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/kaigene-expands-drug-pipeline-through-taisho-deal\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/08\/Kaigene-Enters-into-Exclusive-Licensing-Agreement-with.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/08\/Kaigene-Enters-into-Exclusive-Licensing-Agreement-with.webp","width":1200,"height":800,"caption":"Kaigene"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/kaigene-expands-drug-pipeline-through-taisho-deal\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Kaigene Expands Drug Pipeline Through Taisho Deal"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"author_category":"","first_name":"ITBT","last_name":"StaffWriter","user_url":"https:\/\/itbusinesstoday.com\/","job_title":"","description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002"}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/37202","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=37202"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/37202\/revisions"}],"predecessor-version":[{"id":37207,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/37202\/revisions\/37207"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/37206"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=37202"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=37202"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=37202"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=37202"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}